Stay updated with breaking news from Acumen Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SINGAPORE (The Straits Times/Asia News Network): The battle to fend off the new Omicron coronavirus variant has got a boost from polymerase chain reaction (PCR) test kits developed by home-grown medical technology firm Acumen Diagnostics.
Business Scoop provides news and views on Business and Markets from New Zealand
- Highly accurate, cost-effective, affordable PCR tests with 2 laboratories able to undertake 7000 tests daily
- Aoxin Q & M acquires a stake in Acumen Diagnostics, one of the leading homegrown medical diagnostics and technology companies in Singapore- With Q & M holding a majority 51% stake in Acumen Diagnostics
Aoxin Q & M acquires a stake in Acumen Diagnostics, one of the leading homegrown medical diagnostics and technology companies in Singapor